Medicare Enrolled
Dr. Carl Minniti, MD
Optician · Mickleton, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Minniti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Minniti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Minniti
Dr. Carl Minniti is an optician specialist in Mickleton, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Minniti performed 130,424 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Minniti received a total of $20,966 from 22 pharmaceutical and/or device companies across 64 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Minniti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 1% volume in NJ
$20,966 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗130,424
Medicare services
Top 1% in NJ for optician
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
92,820 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
18,240 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,845 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 3,540 | $19 | $30 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,684 | $8 | $30 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,644 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,090 | $1 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
820 | $12 | $40 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
797 | $25 | $71 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
716 | $102 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
517 | $70 | $150 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
435 | $1 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
418 | $116 | $285 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
411 | $1 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
403 | $150 | $275 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
251 | $17 | $42 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
243 | $55 | $128 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
236 | $1 | $12 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
227 | $13 | $45 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
223 | $0 | $20 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
172 | $25 | $66 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
169 | $7 | $60 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
162 | $58 | $140 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
99 | $146 | $350 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
86 | $101 | $225 |
| New patient office visit, complex (60-74 min) | 56 | $175 | $350 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 49 | $334 | $896 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
43 | $19 | $65 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $48 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
73.1% high complexity
22.9% medium
4.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,966
Total received (2018-2024)
Avg $2,995/year across 7 years
Top 6% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
64
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,381
2023
$1,213
2022
$685
2021
$1,546
2020
$1,178
2019
$10,070
2018
$2,892
Payments by company (2024)
BeiGene USA, Inc.
$1,942
AstraZeneca Pharmaceuticals LP
$1,401
Incyte Corporation
$38
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$5,777
Exelixis Inc.
$3,396
Gilead Sciences, Inc.
$1,991
BeiGene USA, Inc.
$1,942
Athenex Pharmaceutical Division, LLC
$1,867
AstraZeneca Pharmaceuticals LP
$1,474
Janssen Scientific Affairs, LLC
$1,170
Jazz Pharmaceuticals Inc.
$1,100
MorphoSys, US Inc.
$615
E.R. Squibb & Sons, L.L.C.
$489
ASD SPECIALTY HEALTHCARE, LLC
$360
Seattle Genetics, Inc.
$325
ASD Specialty Healthcare, LLC
$178
Lilly USA, LLC
$99
AVEO Pharmaceuticals, Inc.
$52
Amgen Inc.
$40
PFIZER INC.
$25
Janssen Biotech, Inc.
$15
Seagen Inc.
$14
GENZYME CORPORATION
$13
Merck Sharp & Dohme Corporation
$12
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 53.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BENDEKA · BRUKINSA · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · FOTIVDA · IBRANCE · IMFINZI · JEVTANA · KEYTRUDA · Kyprolis · LYNPARZA · MONJUVI · OPDIVO · Oral Paclitaxel · PEMAZYRE · RETEVMO · RYBREVANT · SUTENT · TAGRISSO · TUKYSA · VERZENIO · ZEPZELCA · Zydelig
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
653
County median income
$102,807
Nearest hospital to ZIP centroid (approximate)
CROZER CHESTER MEDICAL CENTER
7.6 mi
7.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Minniti is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Minniti experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Minniti performed 92,820 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Minniti receive payments from pharmaceutical companies?
Yes. Dr. Minniti received a total of $20,966 from 22 companies across 64 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Minniti's costs compare to other opticians in Mickleton?
Dr. Minniti's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Minniti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Mickleton
Browse opticians in Mickleton ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology